失代偿期肝硬化合并急性肾损伤与低凝和高凝特征均相关
这项前瞻性研究比较了40例合并急性肾损伤(AKI)与40例不合并AKI的失代偿期肝硬化患者的血小板、凝血和纤溶三方面止血指标。合并AKI者血小板聚集和分泌降低、因子XIII降低提示出血倾向,而因子VIII升高、蛋白C/S及抗凝血酶降低伴凝血酶生成增加提示高凝状态,纤溶酶-抗纤溶酶复合物升高提示纤溶亢进。AKI缓解后血小板功能与凝血改善,但纤溶仍处于过度激活状态。
要点
- 失代偿期肝硬化合并AKI者血小板聚集和分泌降低,提示血小板功能受损、出血倾向增加。
- 合并AKI者因子VIII升高、蛋白C/S及抗凝血酶降低伴凝血酶生成增加,提示高凝状态。
- AKI缓解后血小板功能和凝血改善至无AKI者水平,但纤溶仍过度激活。
核心结论
- 在失代偿期肝硬化患者中,AKI与低凝和高凝特征均相关,可能同时增加出血和血栓形成风险。
研究设计与样本
- 前瞻性研究,纳入80例失代偿期肝硬化患者,合并AKI与不合并AKI者各40例。
- 止血评估涵盖一期止血(血小板聚集和分泌、血管性血友病因子)、二期止血(促凝与抗凝因子、凝血酶生成)和三级止血(纤溶因子、纤溶酶-抗纤溶酶复合物)。
主要发现
- 两组肝硬化严重程度和血小板计数相当;合并AKI与不合并AKI者中位血清肌酐分别为1.8 mg/dL和0.8 mg/dL。
- 合并AKI者血小板聚集和分泌降低,提示血小板功能受损(出血倾向增加),血管性血友病因子无差异。
- 合并AKI者因子VIII升高,蛋白C、蛋白S和抗凝血酶均降低,伴凝血酶生成增加,提示高凝状态;因子XIII降低(出血倾向增加)。
- 合并AKI者同时存在纤溶受抑和纤溶亢进改变,纤溶酶-抗纤溶酶复合物升高提示纤溶亢进状态。
- AKI缓解后(40例中23例),血小板功能和凝血改善至无AKI的肝硬化患者水平,但纤溶仍过度激活。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Recent evidence suggests that acute kidney injury (AKI) is the main predictor of postparacentesis bleeding in patients with cirrhosis. To assess the factors responsible for bleeding tendency in AKI, we performed a prospective study comparing all three aspects of hemostasis (platelets, coagulation, and fibrinolysis) in patients with decompensated cirrhosis with and without AKI. APPROACH AND RESULTS: Primary hemostasis assessment included platelet aggregation and secretion (platelet function markers) and von Willebrand factor. Secondary hemostasis assessment included pro-coagulant (factor VIII and factor XIII) and anti-coagulant (protein C, protein S, and antithrombin) factors and thrombin generation. Tertiary hemostasis assessment included fibrinolytic factors and plasmin-antiplasmin complex. Eighty patients with decompensated cirrhosis were recruited (40 each with and without AKI). Severity of cirrhosis and platelet count were comparable between groups. Median serum creatinine was 1.8 mg/dL and 0.8 mg/dL in patients with and without AKI, respectively. At baseline, patients with cirrhosis and AKI had lower platelet aggregation and secretion, indicative of impaired platelet function (increased bleeding tendency), without differences in von Willebrand factor. Regarding coagulation factors, factor VIII was higher, whereas protein C, protein S, and antithrombin were all lower, which, together with increased thrombin generation, indicate hypercoagulability. In contrast, factor XIII was lower in AKI (increased bleeding tendency). Finally, while both hypofibrinolytic and hyperfibrinolytic changes were present in AKI, a higher plasmin-antiplasmin complex indicated a hyperfibrinolytic state. After AKI resolution (n = 23 of 40), platelet function and coagulation improved to levels observed in patients with cirrhosis patients without AKI; however, fibrinolysis remained hyperactivated. CONCLUSIONS: In patients with decompensated cirrhosis, AKI is associated with both hypocoagulable and hypercoagulable features that can potentially increase the risk of both bleeding and thrombosis.
引用
- Zanetto A, Rinder HM, Campello E, et al. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features. Hepatology. 2020. PMID: 32614088. doi:10.1002/hep.31443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。